3.4
Vía de señalización dependiente de NF-κB
El factor de transcripción NF-κB fue descubierto en 1986 en el laboratorio del profesor David Baltimore, premio Nobel, por su interacción con el poten…
Las proteínas NF-κB son factores de transcripción que participan en muchas funciones celulares cruciales, como la activación de las células inmunitarias, la adhesión celular, la respuesta antimicrobiana y la regulación del ciclo celular.
En el estado de reposo, el NF-κB existe como un heterodímero unido directamente a una proteína inhibidora llamada IκBɑ. IκBɑ suprime la actividad de NF-κB como activador transcripcional.
La vía de señalización dependiente de NF-κB se activa al unirse un ligando apropiado a su correspondiente receptor de superficie celular en la célula diana.
Por ejemplo, la vía puede desencadenarse mediante la unión del factor de necrosis tumoral-ɑ al receptor TNF, la unión de la interleucina 1 al receptor IL1 o la unión de patógenos a receptores tipo toll.
Esta unión ligando-receptor da lugar a la activación de un complejo proteico, la quinasa IκB, que consta de tres subunidades, ɑ, β y γ.
A continuación, la quinasa activada fosforila la proteína IkB, lo que conduce a su ubiquitinación.
A continuación, la proteína IκB marcada se degrada inmediatamente en el proteasoma.
Como resultado, el dímero NF-κB se libera de IκB y es libre para su translocación al núcleo, donde puede activar la expresión de varios genes diana.
Uno de los genes diana activados por NF-κB es el gen que codifica la proteína IκBɑ. Al aumentar su expresión, IκBɑ ayuda a regular la vía de señalización dependiente de NF-κB a través de un bucle de retroalimentación negativa.
La vía de señalización dependiente de NF-κB actúa para controlar una amplia gama de procesos biológicos, incluida la inmunidad innata y adaptativa y las respuestas inflamatorias al estrés.
Debido a su papel fundamental en las respuestas inmunitarias e inflamatorias de los animales, la desregulación de NF-κB puede provocar varios tipos de cáncer, así como varias enfermedades inflamatorias, como la artritis y el asma.
View the full transcript and gain access to JoVE Core videos
Q1: What is NF-κB and what are its main cellular functions?
NF-κB is a transcription factor that regulates expression of over 100 genes essential for immune and inflammatory responses. It controls crucial cellular functions including immune cell activation, cell adhesion, antimicrobial response, and cell cycle regulation. NF-κB also regulates cell proliferation, apoptosis, and plays diverse roles in the nervous system such as learning and memory.
Q2: How does IκBα regulate NF-κB activity in resting cells?
In resting cells, NF-κB exists as a heterodimer bound to the inhibitory protein IκBα, which suppresses its transcriptional activity. IκBα masks the nuclear localization signals of NF-κB, keeping it inactive in the cytoplasm. This inhibitory mechanism prevents NF-κB from entering the nucleus and activating target genes until an appropriate signal is received.
Q3: What triggers activation of the NF-κB signaling pathway?
The NF-κB pathway activates when ligands bind to cell-surface receptors, such as tumor necrosis factor-α binding to TNF receptor, interleukin-1 binding to IL1 receptor, or pathogens binding to toll-like receptors. These ligand-receptor interactions activate the IκB kinase complex, which phosphorylates IκBα, leading to its ubiquitination and proteasomal degradation, releasing NF-κB for nuclear translocation.
Q4: What happens to NF-κB after IκBα is degraded?
Once IκBα is degraded in the proteasome, the NF-κB dimer is released and free to translocate to the nucleus. In the nucleus, NF-κB acts as a transcriptional activator, binding to DNA and activating expression of target genes. This allows the cell to mount appropriate physiological responses to external stimuli such as pathogens or reactive oxygen species.
Q5: How does NF-κB regulate itself through negative feedback?
NF-κB activates the gene encoding IκBα protein as one of its target genes. Upon increased expression, newly synthesized IκBα binds to NF-κB in the nucleus, causing it to exit and return to the cytoplasm. This negative feedback loop prevents excessive NF-κB signaling and helps maintain cellular homeostasis by limiting the duration and intensity of the immune response.
Q6: What diseases result from dysregulation of NF-κB signaling?
Dysregulation of NF-κB can lead to various cancers and inflammatory diseases such as arthritis and asthma. Additionally, pathogens like HIV, HPV, and Yersinia pestis exploit or interfere with the NF-κB signaling pathway to evade host defense mechanisms. Because of its diverse roles in animals, the NF-κB signaling pathway and associated diseases make it an excellent therapeutic target.
Q7: Why is NF-κB considered a central mediator of immune responses?
NF-κB regulates expression of genes essential for both innate and adaptive immune responses as well as inflammatory stress responses. It controls activation of immune cells, antimicrobial defenses, and inflammatory signaling. Since its discovery in 1986, over three decades of research has revealed that NF-κB coordinates multiple aspects of immune defense, making it central to how animals respond to pathogens and cellular stress.